Bain Capital Specialty Finance Inc
NYSE:BCSF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.28
19.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Bain Capital Specialty Finance Inc
Bain Capital Specialty Finance Inc. operates at the intersection of traditional finance and nimble investment strategies, carving out its niche within the intricate world of specialty lending. As a business development company (BDC), it has crafted a business model that primarily offers customized debt financing solutions to middle-market companies across various industries. These companies, often underserved by larger financial institutions, turn to Bain Capital Specialty Finance for its strategic capital allocation, expert counsel, and flexibility. This specialized focus not only sets the company apart but also positions it robustly within a competitive landscape, enhancing its ability to generate substantial risk-adjusted returns.
The company makes money through interest income on its loan portfolio, as well as potential capital appreciation from any equity investments embedded within the financing structures. By carefully selecting a range of debt investments, Bain Capital Specialty Finance optimizes its portfolio to balance yield and risk while leveraging the broader Bain Capital platform for industry insights and operational expertise. This approach allows the company to deliver value not only to its borrowers but also to its investors, who benefit from its adept navigation of market cycles. The result is a finely tuned investment vehicle that thrives in the complexities of the mid-market realm, continuously seeking opportunities for growth and value creation.
Bain Capital Specialty Finance Inc. operates at the intersection of traditional finance and nimble investment strategies, carving out its niche within the intricate world of specialty lending. As a business development company (BDC), it has crafted a business model that primarily offers customized debt financing solutions to middle-market companies across various industries. These companies, often underserved by larger financial institutions, turn to Bain Capital Specialty Finance for its strategic capital allocation, expert counsel, and flexibility. This specialized focus not only sets the company apart but also positions it robustly within a competitive landscape, enhancing its ability to generate substantial risk-adjusted returns.
The company makes money through interest income on its loan portfolio, as well as potential capital appreciation from any equity investments embedded within the financing structures. By carefully selecting a range of debt investments, Bain Capital Specialty Finance optimizes its portfolio to balance yield and risk while leveraging the broader Bain Capital platform for industry insights and operational expertise. This approach allows the company to deliver value not only to its borrowers but also to its investors, who benefit from its adept navigation of market cycles. The result is a finely tuned investment vehicle that thrives in the complexities of the mid-market realm, continuously seeking opportunities for growth and value creation.
Net Investment Income: Net investment income per share was $0.45, providing a 10.3% annualized yield on book value and covering the dividend by 7%.
Dividend: The Board declared a Q4 dividend of $0.42 per share plus a $0.03 supplemental dividend, totaling $0.45 per share for the quarter.
NAV Decline: Net asset value per share was $17.40, down $0.16 from last quarter, mainly due to a specific loan markdown rather than widespread credit issues.
Portfolio Quality: Nonaccrual investments remained low at 1.5% (cost) and 0.7% (fair value), indicating continued credit health.
New Investments: Gross originations were $340 million in Q3, with a strong focus on first lien senior secured loans and defensive sectors.
Interest Rate Outlook: Management expressed confidence in maintaining the regular dividend even amid expectations for lower interest rates and upcoming debt maturities.
Competitive Positioning: Bain Capital Specialty Finance emphasized disciplined underwriting, a diversified portfolio, and robust due diligence as key differentiators.
